These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 8049429)
1. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. van 't Veer C; Hackeng TM; Delahaye C; Sixma JJ; Bouma BN Blood; 1994 Aug; 84(4):1132-42. PubMed ID: 8049429 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of tissue factor:factor VIIa-catalyzed factor IX and factor X activation by TFPI and TFPI constructs. Peraramelli S; Thomassen S; Heinzmann A; Rosing J; Hackeng TM; Hartmann R; Scheiflinger F; Dockal M J Thromb Haemost; 2014 Nov; 12(11):1826-37. PubMed ID: 25163770 [TBL] [Abstract][Full Text] [Related]
3. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. van 't Veer C; Mann KG J Biol Chem; 1997 Feb; 272(7):4367-77. PubMed ID: 9020158 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. Synergistic effect in combination with tissue factor pathway inhibitor. van 't Veer C; Golden NJ; Kalafatis M; Mann KG J Biol Chem; 1997 Mar; 272(12):7983-94. PubMed ID: 9065469 [TBL] [Abstract][Full Text] [Related]
5. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. Ghosh S; Ezban M; Persson E; Pendurthi U; Hedner U; Rao LV J Thromb Haemost; 2007 Feb; 5(2):336-46. PubMed ID: 17092304 [TBL] [Abstract][Full Text] [Related]
6. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes. Thiec F; Cherel G; Christophe OD J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356 [TBL] [Abstract][Full Text] [Related]
9. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Puy C; Tucker EI; Matafonov A; Cheng Q; Zientek KD; Gailani D; Gruber A; McCarty OJ Blood; 2015 Feb; 125(9):1488-96. PubMed ID: 25587039 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab. Chowdary P Drugs; 2018 Jun; 78(9):881-890. PubMed ID: 29845491 [TBL] [Abstract][Full Text] [Related]
11. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa. Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756 [TBL] [Abstract][Full Text] [Related]
13. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain. Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595 [TBL] [Abstract][Full Text] [Related]
14. Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Hilden I; Lauritzen B; Sørensen BB; Clausen JT; Jespersgaard C; Krogh BO; Bowler AN; Breinholt J; Gruhler A; Svensson LA; Petersen HH; Petersen LC; Balling KW; Hansen L; Hermit MB; Egebjerg T; Friederichsen B; Ezban M; Bjørn SE Blood; 2012 Jun; 119(24):5871-8. PubMed ID: 22563084 [TBL] [Abstract][Full Text] [Related]
15. A new regulatory function of activated factor V: inhibition of the activation by tissue factor/factor VII(a) of factor X. Al Dieri R; Bloemen S; Kelchtermans H; Wagenvoord R; Hemker HC J Thromb Haemost; 2013 Mar; 11(3):503-11. PubMed ID: 23294934 [TBL] [Abstract][Full Text] [Related]
16. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Lindhout T; Blezer R; Schoen P; Nordfang O; Reutelingsperger C; Hemker HC Blood; 1992 Jun; 79(11):2909-16. PubMed ID: 1586738 [TBL] [Abstract][Full Text] [Related]
17. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Camerer E; Huang W; Coughlin SR Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786 [TBL] [Abstract][Full Text] [Related]
19. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex. Ndonwi M; Broze G; Bajaj SP J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274 [TBL] [Abstract][Full Text] [Related]